ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2018

Abstract Number: 2198

Evaluation of 18F-Fluorodeoxyglucose PET-CT Score at Baseline on the Therapeutic Response to Prednisone in Polymyalgia Rheumatica: A Retrospective Study

Nicolas Giraud1, Maxime Sondag2, Aline Charpentier2, Hatem Boulahdour3, Clément Prati4,5, Daniel Wendling6,7 and Frank Verhoeven8, 1Rheumatology, CHU de Besançon, Besançon, France, 2rheumatology, CHU de Besançon, Besancon, France, 3CHU de Besançon, Besançon, France, 4EA 4267 FDE, FHU INCREASE, Université de Bourgogne Franche Comté, Besancon, France, 5Rheumatology, University Hospital - Bourgogne Franche Comté University, Besancon, France, 6Rheumatology, University Hospital - Bourgogne Franche Comté University, Besançon, France, 7EA 4266, Univ. Bourgogne Franche-Comté, F-25000 Besançon, France, F-25000 Besançon, France, 8EA 4267 PEPITE, Université de Bourgogne Franche Comté, Besançon, France

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2018

Keywords: corticosteroids, Imaging, polymyalgia rhuematica and prognostic factors

Session Information

Date: Tuesday, October 23, 2018

Title: Imaging of Rheumatic Diseases Poster III: Other Modalities

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

To evaluate the impact of 18F-fluorodeoxyglucose PET-CT (FDG-PET/CT) score at baseline, on the therapeutic response to prednisone, in patients with polymyalgia rheumatica (PMR).

Methods:

This is a monocentric retrospective study realized at the university hospital of Besancon. We included patients with a diagnosis of PMR meeting the 2012 ACR/EULAR criteria, who had performed a FDG-PET/CT at baseline, between december 2012 and december 2017. Patients were treated with an initial prednisone dose of 0.3mg/kg a day, progressively decreased following a standardized tapering dose protocol (10% /month). We excluded patients who received corticosteroids before the FDG-PET/CT, or without baseline FDG-PET/CT. Seventeen specifics previously described hotspots were visually analyzed (1). We realized a semi-quantitative analysis of FDG uptake (4-point score from 0 to 3), following Goerres scoring system (2). Hotspot with 0 indicating no uptake (same as bone); 1, slight uptake; 2, moderate uptake (same as liver); and 3, uptake higher than the liver. It results in a score of 0 to 51. Then we defined two groups of patients according to their resistance to prednisone at 6 months, defined as the reoccurrence of symptoms and/or an increase of systemic inflammation twice during the prednisone tapering.

Results:

30 patients where included: 12 in the group “resistant “and 18 in the group “sensitive”. There were 60% of women, with a mean age of 67,57 ± 11,63 years. The mean CRP at baseline was 45,02 ± 39,59 mg/L. The mean FDG-PET/CT score at baseline was 18/51. The FDG-PET/CT score baseline was significantly lower in the resistant group (9 vs 23, p<0.009). Resistant patients were younger (60 years vs 74.5 years, p<0.008), and mostly men (66.5% vs 22%, p<0.02). ROC curve shows a predictive threshold of corticoresistance at 9/51 on the PET/CT score at baseline, with 66.67 % of sensibility and 83.37 of specificity [AUC: 0,78 ± 0,08] Patients with peripheral synovitis had higher PET/CT score baseline (p=0.02).

However, there was no statistically significantly difference of CRP at baseline between the two groups (13.75 vs 15, p<0.8), and no correlation between CRP and PET/CT score at baseline ( p=0.17). There was no difference concerning the presence of neoplasia (16.5% vs 11%, p<1.00) in the two groups.

Conclusion:

These data suggest that higher baseline FGD-PET/CT score is predictive of a better response to prednisone in patients with PMR, with a predictive threshold of corticoresistance lower than 9/51 on FDG-PET/CT score at baseline. Corticoresistant patients seemed to be mostly men and younger, with no significantly difference inCRP at baseline.

References:

1 Sondag.M et al. Utility of 18F-fluoro-dexoxyglucose positron emission tomography for the diagnosis of polymyalgia rheumatica: a controlled study. 2016 Aug;55(8):1452-7.

2 . Goerres GW, Forster A, Uebelhart D et al. F-18 FDG whole-body PET for the assessment of disease activity in patients with rheumatoid arthritis. Clin Nucl Med 2006;31:386_90.


Disclosure: N. Giraud, None; M. Sondag, None; A. Charpentier, None; H. Boulahdour, None; C. Prati, None; D. Wendling, None; F. Verhoeven, None.

To cite this abstract in AMA style:

Giraud N, Sondag M, Charpentier A, Boulahdour H, Prati C, Wendling D, Verhoeven F. Evaluation of 18F-Fluorodeoxyglucose PET-CT Score at Baseline on the Therapeutic Response to Prednisone in Polymyalgia Rheumatica: A Retrospective Study [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/evaluation-of-18f-fluorodeoxyglucose-pet-ct-score-at-baseline-on-the-therapeutic-response-to-prednisone-in-polymyalgia-rheumatica-a-retrospective-study/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/evaluation-of-18f-fluorodeoxyglucose-pet-ct-score-at-baseline-on-the-therapeutic-response-to-prednisone-in-polymyalgia-rheumatica-a-retrospective-study/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology